Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 18/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8532621 | 0.88 | ADRB2 (0.59) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8527907 | 0.88 | ADRB2 (0.59) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8531752 | 0.87 | ADRB2 (0.74) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL7795607 | 0.87 | ADRB2 (0.58) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8088349 | 0.78 | ABCB11 (0.73) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL7837307 | 0.76 | ADRB2 (0.80) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL7841548 | 0.75 | ADRB2 (0.61) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8528222 | 0.75 | ABCB11 (0.74) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8134195 | 0.75 | ABCB11 (0.77) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8528251 | 0.75 | ABCB11 (0.73) | ADRB2ABCB11ADRB1DRD2PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0649418-B1 | 7-(2-AMINOETHYL)-BENZOTHIAZOLONES | ASTRA PHARMA PROD (GB) | 1998-10-28 | — | — | EP | disclosed |
| US-5648370-A | 7-(2-aminoethyl) benzothiazolones | ASTRA PHARMACEUTICALS LIMITED (GB) | 1997-07-15 | — | — | US | disclosed |